Jan 13, 2020
Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration with UC Davis in Ongoing Clinical Trial for Patients with HIV-Related Lymphoma
Jan 10, 2020
Announcement of iPSC Derived Gene-modified NK Cell Development Targeting Solid Tumors
Jan 07, 2020
The Global Cancer Tumor Organoids Market, 2025: A $400+ Million Opportunity Assessment
Jan 06, 2020
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab
Jan 06, 2020
Clinical Update - 4D Announce New Study of MRx0518 in Pancreatic Cancer
Dec 19, 2019
Chinese Cancer Drugs Market Outlook to 2025 - Cutting Import Duties on Cancer Drugs Drives the Market
Dec 18, 2019
Quantum Leap Healthcare Collaborative Announces the Selection of Regeneron's Libtayo® (cemiplimab) and REGN3767 for Injection in the I-SPY 2 TRIAL for Breast Cancer
Dec 05, 2019
Cellex Opens New Plant to Manufacture Innovative Cell Therapy Products for Cancer
Dec 04, 2019
OncoHost Opens First-of-its-Kind Proteomics Laboratory for Host Response Analysis for Cancer Therapy
Dec 02, 2019
New Stem Cell Research Could Make Cancer Treatments affordable and Effective for Hospitals and Patients
Nov 18, 2019
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
Nov 13, 2019
Moderate Dose Chemotherapy Doubles Survival Rate in All Ages
Nov 12, 2019
Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program
Nov 12, 2019
Biotechs Seek Advancements in the Immuno-Oncology Field for Childhood Brain Tumors
Nov 12, 2019
GO2 Foundation for Lung Cancer "Simply the Best" Dinner and Gala Honors Those Working on the Front Lines to Fight Lung Cancer
Nov 09, 2019
Rakuten Medical Investigational Anti-cancer Therapy Candidate Seen to Activate Immune System Response and Synergize with PD1 Checkpoint Blockade in Animal Models
Nov 06, 2019
Patients Turn to Advanced Technology in Order to Combat Cancer
Oct 31, 2019
OncoHost: Nature Reviews Cancer Article Outlines Host Response Analysis as New Tool for Precision Medicine in Oncology
Oct 30, 2019
Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution
Oct 24, 2019
Varian ProBeam 360 System Selected by The Ohio State University for New Proton Therapy Center